Pyrazolo pyrimidine derivatives and methods of use thereof
US-2016168151-A1 · Jun 16, 2016 · US
MTOR modulators and uses thereof
US9629843B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9629843-B2 |
| Application number | US-201514731778-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 5, 2015 |
| Priority date | Jul 8, 2008 |
| Publication date | Apr 25, 2017 |
| Grant date | Apr 25, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides methods and compositions for selective modulation of certain protein kinases, and especially mTor complexes. The methods and compositions are particularly useful in inhibiting mTor selectively for therapeutic applications.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for inhibiting cell proliferation of a leukemic cell comprising administration of an effective amount of a compound, or a pharmaceutical acceptable salt thereof, to said cell, wherein the compound has the formula:
Assignees
Inventors
Classifications
Antihypertensives · CPC title
Antineoplastic agents · CPC title
Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure · CPC title
- A61K31/519Primary
ortho- or peri-condensed with heterocyclic rings · CPC title
Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A) · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9629843B2 cover?
- The present invention provides methods and compositions for selective modulation of certain protein kinases, and especially mTor complexes. The methods and compositions are particularly useful in inhibiting mTor selectively for therapeutic applications.
- Who is the assignee on this patent?
- Univ California, Intellikine Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/519. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).